CNS LS

Related by string. CNL * CND . Cn . Cns . cn . -Cnd . Cnd . cnd . CNs . cns . CNER : Citigroup CN Quote Profile . CN PhD . CN Quote Profile . Citigroup CN 行情 . CN Tower . SAN DIEGO CNS . Nuclear Disarmament CND . CN Rail . Citigroup CN . LG CNS . Fiserv EFT CNS / led . Led . LD . Ling . LED . l' . ling . L. . L' . Ls : de l' . Prix de l' . L' s . Robert L. Ehrlich . daily L' Equipe . LED lighting . DE L' . LED lights . LS . L. Dennis Kozlowski * *

Related by context. Frequent words. (Click for all words.) 68 PANSS 68 ADAS cog 64 ADHD RS 64 IPSS 61 DAS# [002] 61 virologic response 59 annualized relapse 59 Disease Activity 59 sustained virologic response 59 plus methotrexate 59 Secondary endpoints included 59 symptom severity 59 placebo p = 58 QoL 58 Secondary endpoints 58 placebo p 58 LVEF 57 ± SD 57 EDSS 57 mg QD 57 Global Impression 57 achieved statistical significance 56 Secondary endpoints include 56 tiotropium 56 serum phosphorus 56 FOLFIRI 56 fasting glucose 56 QTc 55 plus prednisone 55 tocilizumab 55 pramipexole 55 fasting insulin 55 demonstrated statistically significant 55 P = .# 55 cytogenetic response 55 serum uric acid 55 ACR# [002] 55 mg BID 55 peginterferon alfa 2a 54 #mg/kg [002] 54 Cmax 54 active comparator 54 #mg dose [003] 54 Rating Scale 54 PROMACTA 54 subscales 54 C Reactive Protein 54 elagolix 54 pregabalin 54 HbA1c levels 54 CD4 + cell 54 creatinine clearance 54 COPAXONE R 54 nab paclitaxel 54 hsCRP 54 ANOVA 54 citalopram 54 Recurrence Score 54 glimepiride 53 inflammatory lesions 53 median PFS 53 vertebral fracture 53 statistically significant reduction 53 adalimumab 53 glycated hemoglobin 53 hemoglobin concentration 53 TIMI 53 COPAXONE ® 53 statistically significant improvement 53 secondary endpoint 53 TORISEL 53 quetiapine 53 infarct size 53 PEG Intron 53 lacosamide 53 rotigotine 53 coronary artery calcium 53 PCA3 53 mineral density 53 ord = + krdDartOrd 53 tipranavir 53 T2DM 52 azacitidine 52 HRQOL 52 0 document.write 52 noninferiority 52 myocardial perfusion 52 glatiramer acetate 52 esomeprazole 52 MMSE 52 systolic BP 52 depressive symptoms 52 thromboembolic events 52 IU mL 52 secondary efficacy endpoints 52 aripiprazole 52 hemoglobin A1C 52 vasomotor symptoms 52 decitabine 52 fasting plasma glucose 52 preoperatively

Back to home page